At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
Auto-PAPdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Auto-PAP Therapy For Improved Fetal Growth
In Brief
A clinical study evaluating Auto-PAP for Obstructive Sleep Apnea and Pregnancy. Completed, enrolled 43 participants across 1 site.
Detailed Summary
The purpose of this study is to see whether the presence of night-time breathing disturbances ("sleep-disordered breathing") in pregnant women is related to fetal growth patterns. The hypothesis is that fetal growth slows in the 3rd trimester in women with sleep-disordered breathing. Use of a nighttime breathing therapy called auto-PAP could minimize the slowing in fetal growth.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Pregnancy
CountriesUnited States
CollaboratorsResMed Foundation
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartDec 2017
Primary CompletionAug 2020
TodayJul 2026
First PostedOct 23, 2017
Enrollment StartDec 1, 2017
Primary CompletionAug 3, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 8.7 years ago
Interventions
Auto-PAPdevice
Women will be using the Auto-PAP device nightly from randomization to end of pregnancy